We explored the cancer genomic dataset from the cBioPortal to analyze genomic alterations in EGFR, iNOS, mTOR, FGFR, TGFR, and MAP2K1 of 10,953 cancer patients (10,967 samples) from different cancer types. This evidence concerns the gene NOS2 and cancer.